Key points from article :
Virus-based cancer vaccines a new approach in cancer immunotherapy.
Researchers developed ExtraCRAd, a novel cancer vaccine platform.
It consists of oncolytic adenovirus in cancer-cell membrane artificial envelope.
Displays an increased infectivity and oncolytic effect in tumor in vitro and in vivo.
Controls growth of aggressive melanoma and lung tumors.
Serves as next generation of personalized cancer vaccines with enhanced features.
Research by University of Helsinki professors and team.
